Zevin Asset Management LLC Has $11.94 Million Stock Position in Colgate-Palmolive Company $CL

Zevin Asset Management LLC lifted its stake in Colgate-Palmolive Company (NYSE:CL) by 2.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 131,346 shares of the company’s stock after acquiring an additional 2,773 shares during the period. Colgate-Palmolive makes up 1.7% of Zevin Asset Management LLC’s portfolio, making the stock its 25th largest holding. Zevin Asset Management LLC’s holdings in Colgate-Palmolive were worth $11,939,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Westside Investment Management Inc. raised its position in Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after purchasing an additional 130 shares during the last quarter. Cornerstone Planning Group LLC raised its position in shares of Colgate-Palmolive by 1,913.3% in the 1st quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock valued at $28,000 after acquiring an additional 287 shares during the period. Saudi Central Bank acquired a new stake in Colgate-Palmolive during the 1st quarter worth $29,000. Ransom Advisory Ltd acquired a new stake in Colgate-Palmolive during the 1st quarter worth approximately $33,000. Finally, Y.D. More Investments Ltd acquired a new stake in shares of Colgate-Palmolive during the first quarter worth $37,000. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $77.38 on Friday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The company’s 50 day moving average price is $79.84 and its two-hundred day moving average price is $85.88. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The stock has a market cap of $62.54 billion, a P/E ratio of 21.78, a P/E/G ratio of 4.44 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.02. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.17 billion. During the same quarter in the prior year, the firm posted $0.91 EPS. The firm’s quarterly revenue was up 1.9% on a year-over-year basis. On average, equities analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio is currently 58.26%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on CL. UBS Group lowered their price objective on shares of Colgate-Palmolive from $92.00 to $90.00 and set a “buy” rating on the stock in a report on Monday. Barclays reduced their target price on Colgate-Palmolive from $82.00 to $80.00 and set an “equal weight” rating for the company in a research note on Tuesday. Deutsche Bank Aktiengesellschaft set a $86.00 price objective on Colgate-Palmolive in a report on Friday, October 10th. Raymond James Financial dropped their price target on shares of Colgate-Palmolive from $105.00 to $95.00 and set an “outperform” rating for the company in a research report on Monday, October 20th. Finally, Citigroup reduced their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating on the stock in a research note on Monday. Nine investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $89.87.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.